In Vitro Drug Interaction Scientist - Lundbeck at Haeger & Carlsson | Executive Search & Interim AB

Copenhagen, Capital Region of Denmark, Denmark -

Full Time

Start Date

Immediate

Expiry Date

10 Mar, 26

Salary

0.0

Posted On

10 Dec, 25

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Drug-Drug Interaction, Biochemistry, Pharmacy, Chemical Engineering, Enzyme Kinetics, In Vitro Assays, PBPK Modelling, Regulatory Guidelines, Pharmacokinetics, Communication Skills, Scientific Publications, Collaboration, Problem Solving, Decision Making, Quality Focus, Project Strategy

Industry

Staffing and Recruiting

Description

Shape the future of CNS drug development at Lundbeck Haeger & Carlsson, on behalf of Lundbeck, are recruiting an In Vitro Drug Interaction Scientist. As Principal Scientist – in vitro Drug-Drug Interaction (DDI), you will play a key role in the evaluation and prediction of DDI risks for Lundbeck’s development compounds, ensuring safe and effective therapies reach patients. Moreover, as a Departmental representative in the project teams, you will be part of defining the strategy for the projects and will be involved in interactions with health authorities. To support the projects, you will be designing, conducting, interpreting in vitro DDI studies, and develop PBPK models for DDI risk assessment. You will present the outcome to the project teams and guide decision-making in both preclinical and clinical development. Furthermore, for the development projects that you are responsible for, you will be developing the PBPK strategy throughout the development together with the cross functional PBPK team. Qualification Requirements PhD in biochemistry, pharmacy, chemical engineering, or similar experience. Solid experience with major drug-metabolizing enzymes and drug transporters, including enzyme kinetics. Hands-on experience with in vitro DDI assays. Proven track record in the design, execution, and interpretation of in vitro DDI studies. Knowledge of global regulatory guidelines (FDA, EMA, ICH) related to DDI assessment. Industry experience in DDI and pharmacokinetics. Strong communication skills and fluency in English. Preferred Qualifications and Attributes Experience with PBPK modelling and simulation tools (e.g., Simcyp, GastroPlus). Demonstrated ability to prepare regulatory documentation for submissions. Scientific publications in the DDI or ADME field. We are seeking a robust, resilient, and senior scientist who thrives on scientific challenges and collaborative teamwork. You are proactive, quality-focused, and committed to delivering results that make a real difference for patients. Lundbeck is a global pharmaceutical company dedicated to restoring brain health so every person can be their best. For more than 70 years, they have been at the forefront of discovering, developing, and delivering innovative medicines for people living with psychiatric and neurological disorders. Lundbeck pride themselves on scientific excellence, collaboration, and a deep commitment to improving lives. On site: At least 4 days/week Please read more at https://www.lundbeck.com/global Please apply through haegercarlsson.com. Questions are answered by: Alexander Johansson, +46 (0)73 – 77 77 233, alexander@haegercarlsson.com Rolf Carlsson, +46 (0)70-316 12 68, rolf@haegercarlsson.com

Responsibilities

The In Vitro Drug Interaction Scientist will evaluate and predict drug-drug interaction risks for Lundbeck’s compounds and guide decision-making in preclinical and clinical development. The role involves designing, conducting, and interpreting in vitro DDI studies and developing PBPK models for risk assessment.